Abiopharma

🔍 MOORE WILLIAM M (Executive)

Company: IRIDEX CORP (IRIX)

Report Date: 2025-12-11

Detailed Transactions and Holdings:

• Acquired 9,080 shares of Common Stock (Direct)
  Date: 2025-12-11 | Code: P | equity_swap_involved: false | shares_owned_after: 259,754.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 20,920 shares of Common Stock (Direct)
  Date: 2025-12-12 | Code: P | equity_swap_involved: false | shares_owned_after: 280,674.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-12-11 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 69,300.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-12-11 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 30,026.00 | Footnotes: F3

Footnotes:

• F1: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9508 to $0.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
• F2: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9205 to $0.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
• F3: The shares are held by William M. Moore Trust, William M. Moore, Trustee Under Agreement Dated 08/16/2016 & Patricia A. Moore Trust, Patricia A. Moore, Trustee Under Agreement Dated 08/17/2016 Tenants in Common.